The STCC Unified PD1/PDL1 Evaluation of Response (SUPER) study is a collaborative research effort led by the Singapore Translational Cancer Consortium (STCC) aimed at identifying biomarkers that ...

A study featuring investigators from the University at Buffalo Clinical and Translational Science Institute (CTSI), Roswell Park Comprehensive Cancer Center, and CTSA (Clinical and Translational ...

MARLBOROUGH, Mass., April 23, 2025 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (“Akoya”), The Spatial Biology Company ®, today announced a collaboration with the Singapore Translational Cancer ...

OrigAMI-2: A randomized, phase 3 study of amivantamab vs cetuximab, both in combination with FOLFOX or FOLFIRI, as first-line treatment in left-sided RAS/BRAF wild-type metastatic colorectal cancer.

A six-week study from the University of Nottingham suggests that pairing fermented kefir with a diverse prebiotic fiber mix may deliver a powerful anti-inflammatory boost. This “synbiotic” combination ...

In KRAS mutant 2L mCRC, pelareorep delivers prolonged survival benefit with a median PFS and median OS approximately 2.5x the current standard of care Translational data from multiple studies confirm ...

This study proposes a cross-species transcriptomic framework to predict vaccine reactogenicity, with implications for preclinical vaccine safety assessment. The findings show that mouse muscle ...

Pilot study of CBX-12 pharmacodynamics in patients with advanced solid tumors. Background: The gut microbiome (GM) is thought to influence host immunity by modulating multiple immunologic pathways.

Anil Oza is a general assignment reporter at STAT focused on the NIH and health equity. You can reach him on Signal at aniloza.16. The gas xenon, like the other noble, or inert, gases, is known for ...